Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Orion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Orion Corp, Medical Devices Deals, 2012 to YTD 2018 10
Orion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Orion Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Orion and Amgen Enter into Marketing Agreement 12
Orion to Partner with Wisconsin Technology Innovation Initiative 13
Immunscape Enters into Research Collaboration with Orion 14
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 15
Orion Enters into Agreement with Asahi Kasei Pharma 16
Orion Enters into Co-Development Agreement with Helsinki University 17
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 18
Jubilant Biosys Enters Into Drug Discovery Agreement With Orion 19
Orion Enters Into R&D Agreement With Gedeon Richter For Cognitive Disorders 20
Licensing Agreements 21
Aurigene and Orion Enter into Research and Option Agreement for Epigenetics Program 21
Orion Enters Into Licensing Agreement With Janssen Pharma 22
Orion Enters into License Agreement with Phyxius Pharma 23
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 24
Orion And Hospira Extend Licensing Agreement For Precedex 25
Mylan Enters Into Licensing Agreement With Orion for Stalevo 26
Orion Enters Into Licensing Agreement With ProStrakan For Fareston 27
Debt Offering 28
Orion Announces Public Offering Of Bond Due 2019 For US$193 Million 28
Orion Corp – Key Competitors 29
Orion Corp – Key Employees 30
Orion Corp – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Financial Announcements 33
Jul 18, 2018: Orion: Half-year financial report January-June 2018 33
Feb 07, 2018: Orion Group Financial Statement Release for 2017 46
Jul 19, 2017: Orion Group Half-Year Financial Report January-June 2017 53
Apr 26, 2017: Orion Group Interim Report January–March 2017 62
Feb 08, 2017: Orion Group Financial Statement Release for 2016 63
Corporate Communications 66
Sep 19, 2018: Changes in responsibility areas of the Orion Group executive management board 66
Feb 13, 2017: Change in Orion Group Executive Management Board as of 21 February 2017 67
Jan 27, 2017: Reijo Salonen, Senior Vice President, Pharmaceutical R&D, is CTO of the Year 2017 68
Government and Public Interest 69
Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019 69
Feb 10, 2017: Orion Research Foundation grants EUR 1 million for research 71
Product News 72
12/20/2017: Alpha 2 agonizing sedative agent Pressedex Intravenous solution 200 µg Pfizer applies for adaptation to children 72
06/29/2018: CHMP announces recommendations on extensions of therapeutic indication for Dexdor 73
04/05/2017: Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update 74
03/19/2017: Use of levosimendan with heart-lung machine fails to improve outcomes 75
Clinical Trials 76
Sep 01, 2017: Bayer to Present Abstract on Darolutamide at ESMO 2017 Congress 76
May 16, 2017: Tenax Meets with FDA to Discuss Positive Mortality Data and Potential Levosimendan NDA Submission 77
Jan 31, 2017: Tenax Therapeutics Announces Top-Line Results From Phase 3 LEVO-CTS Trial in Cardiac Surgery 78
Other Significant Developments 79
Sep 17, 2018: Creation of novel medicines and better patient care for the future in an ecosystem 79
Jun 14, 2018: Fermion’s new plant operational in Hanko-nearly 100% of production is exported 80
Feb 28, 2018: Orion’s Statutory Co-operation Negotiations Completed 81
Jan 04, 2018: Orion to renew operating model of its laboratories 82
Appendix 83
Methodology 83
About GlobalData 83
Contact Us 83
Disclaimer 83
Orion Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Orion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orion Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Orion Corp, Medical Devices Deals, 2012 to YTD 2018 10
Orion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Orion and Amgen Enter into Marketing Agreement 12
Orion to Partner with Wisconsin Technology Innovation Initiative 13
Immunscape Enters into Research Collaboration with Orion 14
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 15
Orion Enters into Agreement with Asahi Kasei Pharma 16
Orion Enters into Co-Development Agreement with Helsinki University 17
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 18
Jubilant Biosys Enters Into Drug Discovery Agreement With Orion 19
Orion Enters Into R&D Agreement With Gedeon Richter For Cognitive Disorders 20
Aurigene and Orion Enter into Research and Option Agreement for Epigenetics Program 21
Orion Enters Into Licensing Agreement With Janssen Pharma 22
Orion Enters into License Agreement with Phyxius Pharma 23
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 24
Orion And Hospira Extend Licensing Agreement For Precedex 25
Mylan Enters Into Licensing Agreement With Orion for Stalevo 26
Orion Enters Into Licensing Agreement With ProStrakan For Fareston 27
Orion Announces Public Offering Of Bond Due 2019 For US$193 Million 28
Orion Corp, Key Competitors 29
Orion Corp, Key Employees 30
Orion Corp, Subsidiaries 31
List of Figures
Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Orion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Orion Corp, Medical Devices Deals, 2012 to YTD 2018 10